BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 29041937)

  • 1. Biocompatible coated magnetosome minerals with various organization and cellular interaction properties induce cytotoxicity towards RG-2 and GL-261 glioma cells in the presence of an alternating magnetic field.
    Hamdous Y; Chebbi I; Mandawala C; Le Fèvre R; Guyot F; Seksek O; Alphandéry E
    J Nanobiotechnology; 2017 Oct; 15(1):74. PubMed ID: 29041937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of non-pyrogenic magnetosome minerals coated with poly-l-lysine leading to full disappearance of intracranial U87-Luc glioblastoma in 100% of treated mice using magnetic hyperthermia.
    Alphandéry E; Idbaih A; Adam C; Delattre JY; Schmitt C; Guyot F; Chebbi I
    Biomaterials; 2017 Oct; 141():210-222. PubMed ID: 28689117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biodegraded magnetosomes with reduced size and heating power maintain a persistent activity against intracranial U87-Luc mouse GBM tumors.
    Alphandéry E; Idbaih A; Adam C; Delattre JY; Schmitt C; Gazeau F; Guyot F; Chebbi I
    J Nanobiotechnology; 2019 Dec; 17(1):126. PubMed ID: 31870376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced antitumor efficacy of biocompatible magnetosomes for the magnetic hyperthermia treatment of glioblastoma.
    Le Fèvre R; Durand-Dubief M; Chebbi I; Mandawala C; Lagroix F; Valet JP; Idbaih A; Adam C; Delattre JY; Schmitt C; Maake C; Guyot F; Alphandéry E
    Theranostics; 2017; 7(18):4618-4631. PubMed ID: 29158849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Comparative Study of Receptor-Targeted Magnetosome and HSA-Coated Iron Oxide Nanoparticles as MRI Contrast-Enhancing Agent in Animal Cancer Model.
    Erdal E; Demirbilek M; Yeh Y; Akbal Ö; Ruff L; Bozkurt D; Cabuk A; Senel Y; Gumuskaya B; Algın O; Colak S; Esener S; Denkbas EB
    Appl Biochem Biotechnol; 2018 May; 185(1):91-113. PubMed ID: 29082480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation of chains of magnetosomes, isolated from Magnetospirillum magneticum strain AMB-1 magnetotactic bacteria, yielding efficient treatment of tumors using magnetic hyperthermia.
    Alphandéry E; Guyot F; Chebbi I
    Int J Pharm; 2012 Sep; 434(1-2):444-52. PubMed ID: 22698862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chains of magnetosomes with controlled endotoxin release and partial tumor occupation induce full destruction of intracranial U87-Luc glioma in mice under the application of an alternating magnetic field.
    Alphandéry E; Idbaih A; Adam C; Delattre JY; Schmitt C; Guyot F; Chebbi I
    J Control Release; 2017 Sep; 262():259-272. PubMed ID: 28713041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-pyrogenic highly pure magnetosomes for efficient hyperthermia treatment of prostate cancer.
    Nguyen TN; Chebbi I; Le Fèvre R; Guyot F; Alphandéry E
    Appl Microbiol Biotechnol; 2023 Feb; 107(4):1159-1176. PubMed ID: 36633624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biocompatible and stable magnetosome minerals coated with poly-l-lysine, citric acid, oleic acid, and carboxy-methyl-dextran for application in the magnetic hyperthermia treatment of tumors.
    Mandawala C; Chebbi I; Durand-Dubief M; Le Fèvre R; Hamdous Y; Guyot F; Alphandéry E
    J Mater Chem B; 2017 Sep; 5(36):7644-7660. PubMed ID: 32264239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetosomes Extracted from
    Mannucci S; Tambalo S; Conti G; Ghin L; Milanese A; Carboncino A; Nicolato E; Marinozzi MR; Benati D; Bassi R; Marzola P; Sbarbati A
    Contrast Media Mol Imaging; 2018; 2018():2198703. PubMed ID: 30116160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chains of magnetosomes extracted from AMB-1 magnetotactic bacteria for application in alternative magnetic field cancer therapy.
    Alphandéry E; Faure S; Seksek O; Guyot F; Chebbi I
    ACS Nano; 2011 Aug; 5(8):6279-96. PubMed ID: 21732678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bio-synthesized iron oxide nanoparticles for cancer treatment.
    Alphandéry E
    Int J Pharm; 2020 Aug; 586():119472. PubMed ID: 32590095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unlocking the Potential of Magnetotactic Bacteria as Magnetic Hyperthermia Agents.
    Gandia D; Gandarias L; Rodrigo I; Robles-García J; Das R; Garaio E; García JÁ; Phan MH; Srikanth H; Orue I; Alonso J; Muela A; Fdez-Gubieda ML
    Small; 2019 Oct; 15(41):e1902626. PubMed ID: 31454160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic-field induced rotation of magnetosome chains in silicified magnetotactic bacteria.
    Blondeau M; Guyodo Y; Guyot F; Gatel C; Menguy N; Chebbi I; Haye B; Durand-Dubief M; Alphandery E; Brayner R; Coradin T
    Sci Rep; 2018 May; 8(1):7699. PubMed ID: 29769616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of iron-chelating agents on Magnetospirillum magneticum strain AMB-1: stimulated growth and magnetosome production and improved magnetosome heating properties.
    Alphandéry E; Amor M; Guyot F; Chebbi I
    Appl Microbiol Biotechnol; 2012 Nov; 96(3):663-70. PubMed ID: 22707052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smart Magnetotactic Bacteria Enable the Inhibition of Neuroblastoma under an Alternating Magnetic Field.
    Chen C; Wang P; Chen H; Wang X; Halgamuge MN; Chen C; Song T
    ACS Appl Mater Interfaces; 2022 Mar; 14(12):14049-14058. PubMed ID: 35311270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Learning from magnetotactic bacteria: A review on the synthesis of biomimetic nanoparticles mediated by magnetosome-associated proteins.
    Peigneux A; Valverde-Tercedor C; López-Moreno R; Pérez-González T; Fernández-Vivas MA; Jiménez-López C
    J Struct Biol; 2016 Nov; 196(2):75-84. PubMed ID: 27378728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applications of Magnetotactic Bacteria, Magnetosomes and Magnetosome Crystals in Biotechnology and Nanotechnology: Mini-Review.
    Vargas G; Cypriano J; Correa T; Leão P; Bazylinski DA; Abreu F
    Molecules; 2018 Sep; 23(10):. PubMed ID: 30249983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A quantitative assessment of the membrane-integral sub-proteome of a bacterial magnetic organelle.
    Raschdorf O; Bonn F; Zeytuni N; Zarivach R; Becher D; Schüler D
    J Proteomics; 2018 Feb; 172():89-99. PubMed ID: 29054541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural purity of magnetite nanoparticles in magnetotactic bacteria.
    Fischer A; Schmitz M; Aichmayer B; Fratzl P; Faivre D
    J R Soc Interface; 2011 Jul; 8(60):1011-8. PubMed ID: 21247944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.